Alanine aminotransferase (ALT) is one of the most widely used biomarkers for assessing liver cell injury in clinical laboratories worldwide. This article provides a comprehensive clinical analysis of ALT, covering its biochemical principles, testing samples, test items, detection methods, clinical applications, and frequently asked questions. Understanding ALT testing is essential for the accurate diagnosis and monitoring of liver disease.
Technical Overview
Alanine aminotransferase (ALT, EC 2.6.1.2), formerly known as serum glutamate pyruvate transaminase (SGPT), is a pyridoxal phosphate-dependent enzyme that catalyzes the reversible transamination reaction between L-alanine and alpha-ketoglutarate, producing pyruvate and L-glutamate. ALT is found predominantly in the cytoplasm of hepatocytes, with the liver containing the highest concentration of the enzyme in the human body. Because of this tissue distribution, ALT is considered the most liver-specific enzyme routinely measured in clinical chemistry, making it a sensitive indicator of hepatocellular damage.
Under normal physiological conditions, only low levels of ALT are present in the bloodstream. When hepatocytes are injured, inflamed, or destroyed, the cell membrane permeability increases and ALT is released into the circulation, causing serum ALT activity to rise, often before clinical symptoms appear. The magnitude and duration of ALT elevation provide important diagnostic clues: mild elevations are commonly associated with fatty liver disease, alcohol consumption, or strenuous exercise, while marked elevations exceeding ten times the upper reference limit suggest acute viral hepatitis, ischemic hepatitis, or toxic liver injury such as acetaminophen overdose.
Typical adult reference intervals are approximately 7 to 40 U/L for women and 9 to 50 U/L for men, although exact limits vary between laboratories and assay platforms. Interpretation should always be performed in conjunction with aspartate aminotransferase (AST), alkaline phosphatase (ALP), gamma-glutamyl transferase (GGT), bilirubin, and the patient's clinical context, including the AST/ALT ratio, also known as the De Ritis ratio.
Testing Samples
Serum Samples
Serum collected from a plain tube or a separator gel tube is the most common specimen for ALT determination. Venous blood should be drawn using standard aseptic technique, allowed to clot completely for 20 to 30 minutes, and centrifuged to obtain a clear, non-hemolyzed serum sample. ALT in serum is generally stable for up to 3 days when stored at 2 to 8 degrees Celsius, and for several months when frozen at -20 degrees Celsius or below.
Plasma Samples
Heparinized or EDTA plasma may also be used, provided the assay has been validated for that anticoagulant. Plasma offers the advantage of rapid processing without waiting for clot formation, which is particularly useful in emergency and point-of-care settings. Citrate plasma is usually not recommended because the dilution effect can artificially lower the measured enzyme activity.
Pre-Analytical Considerations
- Fasting for 8 to 12 hours is preferred, as recent fatty meals may cause lipemia and interfere with optical measurement, though ALT itself is not dramatically affected by fasting status.
- Hemolysis must be avoided because intracellular enzyme release and optical interference can falsely elevate results.
- Vigorous physical exercise, recent alcohol intake, and certain medications should be documented, as they can cause genuine mild ALT elevations.
- Sample tubes should be filled correctly and gently inverted to ensure proper mixing with anticoagulant when plasma is used.
Testing Items
The core testing item is serum or plasma ALT activity, reported in units per liter (U/L). Depending on the clinical indication, ALT is frequently ordered as part of comprehensive panels rather than in isolation.
- Liver function panel: ALT, AST, ALP, GGT, total and direct bilirubin, total protein, and albumin.
- Hepatitis workup: ALT combined with hepatitis B surface antigen, hepatitis C antibody, and hepatitis A IgM for etiological diagnosis.
- AST/ALT ratio (De Ritis ratio): a ratio above 2 suggests alcoholic liver disease, while a ratio below 1 is more typical of viral hepatitis and non-alcoholic fatty liver disease.
- Serial ALT monitoring: repeated measurements to track disease progression, treatment response, or drug-induced liver injury recovery.
- Optional pyridoxal phosphate stimulation test: compares ALT activity with and without vitamin B6 cofactor to detect underlying deficiency.
Testing Methods
The internationally recommended reference method is the IFCC (International Federation of Clinical Chemistry and Laboratory Medicine) optimized kinetic method, first published in 2002 and refined in subsequent revisions. This is a coupled enzymatic UV assay performed at 37 degrees Celsius.
In the reaction, ALT catalyzes the conversion of L-alanine and alpha-ketoglutarate to pyruvate and L-glutamate. The pyruvate is then reduced to lactate by lactate dehydrogenase (LDH) with simultaneous oxidation of NADH to NAD. The rate of decrease in NADH absorbance, monitored at 340 nm, is directly proportional to ALT catalytic activity. Because the assay relies on spectrophotometric detection, hemolyzed, icteric, or severely lipemic samples may interfere with the measurement and require rejection or pretreatment.
- Kinetic UV assay (IFCC method): the gold standard for automated chemistry analyzers, offering high precision and standardized conditions with NADH, LDH, L-alanine, and Tris buffer at pH 7.15, with or without pyridoxal-5-phosphate activation.
- Dry chemistry slide technology: used in point-of-care and rapid analyzers, providing fast turnaround for urgent clinical settings.
- Enzymatic cycling methods: enhanced sensitivity assays that amplify signal, useful for detecting very low ALT activity in specialized research.
- Quality control: two-level control materials should be run daily, and results verified against established reference intervals and the laboratory's analytical measurement range.
Applications
ALT testing has broad clinical and public health applications. It serves as a first-line tool in the evaluation of suspected liver disease and as a monitoring parameter across multiple medical disciplines.
- Detection and grading of hepatocellular injury in acute and chronic viral hepatitis, guiding antiviral therapy decisions and monitoring treatment response.
- Screening and longitudinal management of metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD) and alcoholic liver disease.
- Monitoring for drug-induced liver injury (DILI) in patients taking hepatotoxic medications such as statins, anti-tuberculosis drugs, methotrexate, and chemotherapy agents.
- Evaluation of unexplained fatigue, jaundice, right upper quadrant pain, dark urine, or pruritus during routine health examinations.
- Assessment of liver involvement in systemic conditions including heart failure with hepatic congestion, sepsis, celiac disease, thyroid disorders, and hemochromatosis.
- Blood donor screening and occupational health surveillance programs to protect transfusion safety and worker health.
FAQ
What does a high ALT level mean?
An elevated ALT level indicates hepatocellular injury but is not a diagnosis by itself. Mild elevations, defined as up to five times the upper reference limit, are most often caused by fatty liver disease, alcohol use, or medication effects. Severe elevations above ten times the upper limit strongly suggest acute viral hepatitis, ischemic hepatitis, or toxic injury, and require urgent evaluation with a full liver panel and viral serology.
Can exercise or diet affect ALT results?
Yes. Strenuous exercise within 24 to 48 hours before testing can transiently raise ALT through muscle and liver enzyme release. Heavy alcohol consumption, obesity, and a high-fat diet can also produce genuine mild elevations. Patients should avoid intense exercise and alcohol for at least 24 to 72 hours prior to testing for the most representative result.
Is fasting required for an ALT test?
Strict fasting is not mandatory because ALT activity changes minimally with food intake. However, an 8 to 12 hour fast is commonly recommended because ALT is usually ordered with other liver parameters such as bilirubin and lipids, which are affected by recent meals and lipemia.
What is the difference between ALT and AST?
Both are aminotransferases released during cell injury, but ALT is located mainly in the cytoplasm of liver cells and is more liver-specific, whereas AST is found in liver, heart, skeletal muscle, kidney, and red blood cells. A disproportionately high AST relative to ALT often points to alcoholic liver disease or muscle injury, while ALT-predominant elevation favors viral or metabolic fatty liver disease.
How can elevated ALT be managed?
Management depends on the underlying cause. General measures include alcohol cessation, weight loss of 5 to 10 percent of body weight for fatty liver disease, discontinuation or dose adjustment of hepatotoxic drugs under medical supervision, adequate glycemic control, and vaccination against hepatitis A and B when appropriate. Persistent or severe elevation should be referred to a hepatologist for further workup, which may include imaging, fibrosis assessment, or liver biopsy.
Can ALT be falsely low?
Yes. Low ALT activity can occur in vitamin B6 (pyridoxine) deficiency, chronic kidney disease, and advanced age with frailty or reduced liver synthetic capacity. Some studies associate persistently low ALT with increased long-term mortality risk, so unusually low values should not be automatically dismissed as reassuring.